Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 404

The DOI matches its Crossref record.

Angiotensin-(1-7) Dilates Canine Coronary Arteries Through Kinins and Nitric Oxide

Brosnihan, K. Bridget, Li, Ping, Ferrario, Carlos M.·1996·Hypertension

Abstract

Abstract Angiotensin-(1-7) [Ang-(1-7)] was recently recognized to have novel biological functions that are distinct from those of Ang II. In these studies, we determined the vasoactive effects of Ang-(1-7) together with the endothelium-dependent mediator(s) of these responses in canine coronary arteries. Isometric tension was measured in intact canine coronary artery rings suspended in organ chambers perfused with 95% O 2/5% CO 2 at 37°C. Ang-(1-7) caused significant concentration-dependent vascular relaxation (2.73±0.58 μmol/L, EC 50) of rings precontracted with the thromboxane A 2 analogue U46,619. Pretreatment with the nitric oxide synthase inhibitor Nω-nitro-l-arginine (1 mol/L) abolished the vasodilator response to Ang-(1-7), whereas treatment with the cyclooxygenase inhibitor indomethacin (10 μmol/L) was without effect. The vasodilator response produced by Ang-(1-7) was blocked by 75% with the bradykinin B 2 receptor antagonist Hoe 140 (1 μmol/L) or by 80% with the nonselective Ang II antagonist [Sar 1,Thr 8]-Ang II (1 μmol/L). In contrast, the selective AT 1 or AT 2 Ang II antagonists CV 11974 (1 μmol/L) and PD 123319 (1 μmol/L), respectively, were ineffective in inhibiting the Ang-(1-7)–elicited vasodilation. Furthermore, pretreatment of the coronary rings with 2 μmol/L Ang-(1-7) markedly potentiated the bradykinin response. These results suggest that Ang-(1-7) elicits coronary vasodilation that is specifically mediated by the endothelium-dependent release of nitric oxide. These responses involve a B 2 bradykinin receptor and a non-AT 1, non-AT 2 angiotensin receptor. These data suggest that increases in circulating levels of Ang-(1-7) accompanying long-term administration of converting enzyme inhibitors or Ang II receptor blockers may contribute to the cardioprotective actions of these drugs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.hyp.27.3.523

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 404

Metadata

Authors
Brosnihan, K. B., Li, P., & Ferrario, C. M.
Venue
Hypertension
Published
1996-03
Volume
27
Issue
3
Pages
523-528
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
OpenAlex
W2080248232
Cited by
404
References
0
FWCI
16.48
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Angiotensin-(1-7) Dilates Canine Coronary Arteries Through Kinins and Nitric Oxide. https://app.cochat.ai/papers/10.1161/01.hyp.27.3.523
The paper
Brosnihan, K. B., Li, P., & Ferrario, C. M. (1996). Angiotensin-(1-7) Dilates Canine Coronary Arteries Through Kinins and Nitric Oxide. Hypertension. https://doi.org/10.1161/01.hyp.27.3.523

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.